We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Sourcebio International Plc | LSE:SBI | London | Ordinary Share | GB00BKSB1674 | ORD GBP0.0015 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 115.00 | 105.00 | 150.00 | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMSBI
RNS Number : 6179Q
SourceBio International PLC
28 October 2021
28 October 2021
SourceBio International plc
(" SourceBio", the "Company" or the "Group")
Director/PDMR Shareholding
SourceBio International plc has been notified that on 20 October 2021, Harwood Capital LLP made the following notifiable transactions; (i) Harwood Capital LLP transferred 5,453,161 and 655,164 ordinary shares of 0.15 pence each in the Company ("Ordinary Shares") to Oryx International Growth Fund Limited ("Oryx") and North Atlantic Smaller Companies Investment Trust plc ("NASCIT"), respectively; and (ii) Harwood Capital LLP disposed of 1,399,517 Ordinary Shares.
Christopher Mills, Non-Executive Director of the Company is Chief Executive of Harwood Capital LLP and has control of investment decisions in relation to Oryx and NASCIT. Following the transactions, Harwood Capital LLP and Christopher Mills are beneficially interested in 20,275,680 Ordinary Shares, representing 27.3% of the issued share capital of the Company.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1 Details of the person discharging managerial responsibilities / person closely associated a) Name Harwood Capital LLP and Harwood Management (Gibraltar) Ltd, investment managers --------------------------------------- -------------------------------------------------- 2 Reason for the notification ------------------------------------------------------------------------------------------- a) Position/status Christopher Mills is a non-executive director of the issuer and Chief Executive of the investment managers --------------------------------------- -------------------------------------------------- b) Initial notification Initial Notification /Amendment --------------------------------------- -------------------------------------------------- 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ------------------------------------------------------------------------------------------- a) Name SourceBio International Plc --------------------------------------- -------------------------------------------------- b) LEI 213800KY4C9WU7WBW518 --------------------------------------- -------------------------------------------------- 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted ------------------------------------------------------------------------------------------- a) Description of the Ordinary shares of GBP0.0015 each financial instrument, type of instrument Identification code GB00BKSB1674 b) Nature of the transaction (i) Transfer of shares (ii) Disposal of shares --------------------------------------- -------------------------------------------------- c) Price(s) and volume(s) (i) ---------------------- ----------------------- Price(s) Volume(s) ---------------------- ----------------------- Nil 5,453,161 ---------------------- ----------------------- Nil 655,164 ---------------------- ----------------------- (ii) ---------------------- ----------------------- Price(s) Volume(s) ---------------------- ----------------------- 125.00p 1,339,517 ---------------------- ----------------------- d) Aggregated information - Aggregated volume (i) - Price 6,108,325 Nil (ii) N/A - Single transaction e) Date of the transaction 20 October 2021 f) Place of the transaction London Stock Exchange --------------------------------------- --------------------------------------------------
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHFLFSFIDLTFIL
(END) Dow Jones Newswires
October 28, 2021 08:55 ET (12:55 GMT)
1 Year Sourcebio Chart |
1 Month Sourcebio Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions